Correlation Between Metacrine and Codiak BioSciences
Can any of the company-specific risk be diversified away by investing in both Metacrine and Codiak BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacrine and Codiak BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacrine and Codiak BioSciences, you can compare the effects of market volatilities on Metacrine and Codiak BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacrine with a short position of Codiak BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacrine and Codiak BioSciences.
Diversification Opportunities for Metacrine and Codiak BioSciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Metacrine and Codiak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and Codiak BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codiak BioSciences and Metacrine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacrine are associated (or correlated) with Codiak BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codiak BioSciences has no effect on the direction of Metacrine i.e., Metacrine and Codiak BioSciences go up and down completely randomly.
Pair Corralation between Metacrine and Codiak BioSciences
If you would invest (100.00) in Codiak BioSciences on December 30, 2024 and sell it today you would earn a total of 100.00 from holding Codiak BioSciences or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Metacrine vs. Codiak BioSciences
Performance |
Timeline |
Metacrine |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Codiak BioSciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Metacrine and Codiak BioSciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Metacrine and Codiak BioSciences
The main advantage of trading using opposite Metacrine and Codiak BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacrine position performs unexpectedly, Codiak BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciences will offset losses from the drop in Codiak BioSciences' long position.Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
Codiak BioSciences vs. BRP Inc | Codiak BioSciences vs. Magnite | Codiak BioSciences vs. Magna International | Codiak BioSciences vs. Interpublic Group of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |